Medicare billing address
CMS Medicare provider billing file
222 Piedmont AveCincinnati, OH 45219
CMS public data · NPI 1306053707
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Kerith E Spicknall, M.D.
Specialty
Credential
M.D.
NPI
1306053707
Primary source state
OH
Data retrieval date
July 26, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Kerith E Spicknall, M.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
222 Piedmont AveCMS Doctors & Clinicians file
222 Piedmont AveIn the 2024 CMS provider billing file, this NPI had 2,086 Medicare beneficiaries and 4,091 total services. The average beneficiary age was 75, and the average HCC risk score was 1.2.
Total Medicare allowed amount
$272,098.67
Total Medicare payment amount
$198,765.90
Medicare beneficiaries
2,086
Total services
4,091
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
73%
CMS beneficiary-panel share
Ischemic heart disease
31%
CMS beneficiary-panel share
Chronic kidney disease
26%
CMS beneficiary-panel share
Diabetes
26%
CMS beneficiary-panel share
Atrial fibrillation
19%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Pathology examination of tissue using a microscope, intermediate complexity | 3,229 | $65.21 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 144 | $85.71 |
| Pathology examination of tissue using a microscope, moderately low complexity | 81 | $39.11 |
| Pathology examination of tissue using a microscope, intermediate complexity | 67 | $34.44 |
| Special stained specimen slides to examine tissue, initial procedure | 65 | $94.93 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 63 | $120.98 |
| Special stained specimen slides to examine tissue, each additional procedure | 51 | $77.10 |
| Biopsy of related skin growth, first growth | 42 | $90.20 |
| Destruction of precancer skin growth, 1 growth | 42 | $51.66 |
| Special stained specimen slides to identify organisms including interpretation and report | 34 | $100.09 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1306053707. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Triamcinolone Acetonide | Triamcinolone Acetonide | 47 | 51.3 | $441.96 |
| 2 | Ketoconazole | Ketoconazole | 36 | 38.5 | $300.17 |
| 3 | Dupixent Pen | Dupilumab | 31 | 31 | $116,183.44 |
| 4 | Hydrocortisone | Hydrocortisone | 28 | 28.2 | $103.48 |
| 5 | Gabapentin | Gabapentin | 25 | 25.1 | $134.53 |
| 6 | Fluocinonide | Fluocinonide | 24 | 26 | $1,330.49 |
| 7 | Clobetasol Propionate | Clobetasol Propionate | 22 | 22.1 | $1,787.73 |
| 8 | Methotrexate | Methotrexate Sodium | 19 | 43.4 | $458.93 |
| 9 | Tacrolimus | Tacrolimus | 17 | 17 | $2,582.15 |
| 10 | Hydroxyzine Hcl | Hydroxyzine Hcl | 12 | 12 | $277.32 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
University Of Pittsburgh School Of Medicine
Graduation year
2005
Group/practice field
University Of Cincinnati Physicians Company Llc
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.